Menu

Focus On

260609_DGIIN2026_653x337px

DGIIN/ÖGIAIN 2026 – BERLIN

From June 17–19, Berlin will host the 57th Joint Annual Meeting of the German Society of Internal Intensive Care and Emergency Medicine (DGIIN) and the Austrian Society of Internal and General Intensive Care and Emergency Medicine (ÖGIAIN), one of the most important scientific events for intensivists and acute care specialists in the German-speaking world.
We are pleased to support the industry-sponsored symposium: “Endotoxic (Septic) Shock and Polymyxin B HemoAdsorption: why and when”, which will take place on Thursday, June 18, from 13:00 to 13:30.

260608_Focus-On_VICENZA-COURSE_653x337px

Vicenza Course AKI-CRRT-EBPT 2026

The 44th VICENZA COURSE on AKI-CRRT-EBPT and Critical Care Nephrology (June 16–18, 2026) is fast approaching, bringing together leading international experts in Critical Care Nephrology, extracorporeal therapies, and organ support. On June 16 at 14:00, we are proud to support the Meet the Experts session “Polymyxin B Hemoadsorption: translating evidence into practice in Endotoxic Septic Shock”.

260508_SMART2026_653x337px

SMART MEETING 2026 – MILANO

We will once again participate in the 37th edition of SMART Meeting Anesthesia Resuscitation Intensive Care, taking place from May 27 to 29, 2026, at Allianz MiCo, Milan.
As a partner of the congress, we will support two scientific sessions focused on extracorporeal organ support and endotoxic septic shock, with international experts discussing some of the most relevant challenges in intensive care medicine. We will also be present throughout the congress at our exhibition stand, where visitors can meet our team and learn more about our technologies and clinical solutions for critical care.

260417_Focus-On_TIGRIS_REV_653x337px

TIGRIS TRIAL RESULTS PUBLISHED

The TIGRIS trial results have been published in The Lancet Respiratory Medicine. In patients with endotoxic septic shock, Polymyxin B Hemoadsorption is associated with a high probability of lower mortality at 28 and 90 days. The Tigris trial shows a clinically meaningful signal of reduced mortality with polymyxin B in patients with ESS, alongside an acceptable safety profile.

260506_Focus-On_Certificati_EN_653x337px

ESTOR OBTAINS ISO 13485 CERTIFICATION

ESTOR has obtained ISO 13485 certification, the international reference standard for quality management systems in the medical device sector. This achievement is a concrete recognition of the company’s ongoing commitment to safety, regulatory compliance, and the high performance of its products, further confirming its position as a reliable and innovative partner in the medical field.

250813_Focus-On_TIGRIS_653x337px

TIGRIS TRIAL RESULTS

Positive topline results from the Tigris trial have just been announced. This phase 3 follow-on sponsored study evaluates the use of Polymyxin B Hemoadsorption (“PMX” – Toray Medical Inc, Tokyo) in a randomized clinical trial of adults treated for Endotoxic Septic Shock (ESS) selected using the Endotoxin Activity Assay (EAA – Spectral Medical Inc., Toronto).

250623_Focus-On_VICENZA-COURSE_653x337px

Vicenza Course AKI-CRRT-EBPT 2025

The 43rd VICENZA COURSE on AKI-CRRT-EBPT and Critical Care Nephrology (June 24-26) is approaching. On June 25 at 2 pm, we will support the Meet The Expert session “Sepsis-Associated AKI and EBPTs approach: ‘endotype’, ‘dose’ or ‘membrane’? That’s the question” where key experts will discuss the most recent findings and clinical strategies for endotoxic shock management.

250430_SMART2025_653x337px

SMART Meeting 2025 – Milano

The 36th SMART Meeting (Smart Meeting Anesthesia Resuscitation Intensive Care) is approaching and will take place from May 7 to 9, 2025, in Milan—Allianz MiCO.
We are partnering with SMART, and on May 7, we will support the session “Clinical Challenges in the ICU and Advanced ExtraCorporeal Organ Support.”

SARNEPI-2024_653x337px

SARNePI – Rome

The 26th National Congress of the Italian Society for Neonatal and Pediatric Anesthesia and Resuscitation (SARNePI) will take place in Rome on November 07-09, 2024.
We are a partner of SARNePI and on November 8, we will support the lecture “Sistemi di depurazione endotossinica nella sepsi pediatrica. Esperienza in OPBG”